North America Active Pharmaceutical Ingredients Market to Witness 5.8% CAGR until 2032

North America Active Pharmaceutical Ingredients Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 5.8% (2024-2032)

Market Size in 2023: USD 74.1 Billion

Market Forecast in 2032: USD 123.1 Billion

According to the latest report by IMARC Group, the North America active pharmaceutical ingredient market size reached USD 74.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 123.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The (API) market is influenced by the increasing demand for generic drugs. 

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/north-america-active-pharmaceutical-ingredients-market/requestsample

North America Active Pharmaceutical Ingredients Industry Trends and Drivers:

1. Growth in Generic Medications

  • Patent expirations for numerous blockbuster drugs are pushing pharmaceutical companies to turn to generics to maintain profitability and market share.
  • Rising demand for affordable healthcare and an aging population in North America are further driving the generics market.
  • This trend boosts the need for Active Pharmaceutical Ingredients (APIs) and encourages investment in high-quality generic development.

2. Outsourcing of API Production

  • Pharmaceutical companies are increasingly outsourcing API production to contract manufacturing organizations (CMOs) to reduce costs and increase efficiency.
  • Outsourcing is driven by the need for specialized manufacturing capabilities and the challenges of meeting complex regulatory requirements.
  • Smaller companies particularly benefit from partnering with CMOs to manage production without the heavy burden of regulatory compliance.

3. Emphasis on Biopharmaceuticals

  • The rise of biopharmaceuticals, such as monoclonal antibodies and therapeutic proteins, has revolutionized treatment approaches and increased demand for complex APIs.
  • The production of biologics requires sophisticated API manufacturing, driving innovation in the field.
  • Regulatory agencies like the FDA are adapting their frameworks to support the development of advanced therapies, encouraging investment in research and development.

4. Innovation in API Manufacturing

  • A focus on drug safety and efficacy is spurring innovation in API manufacturing processes.
  • Advancements include technologies such as continuous manufacturing and real-time quality monitoring.
  • These innovations are enhancing both the efficiency and quality of API production.

5. Impact of COVID-19 on API Supply Chain

  • The COVID-19 pandemic highlighted the need for a resilient API supply chain, leading manufacturers to reassess sourcing strategies.
  • Many companies are focusing on localizing production to mitigate disruptions.
  • There is a renewed emphasis on building a robust domestic API supply chain to enhance production capabilities and ensure regulatory compliance.

North America Active Pharmaceutical Ingredients Industry Segmentation:

The report has segmented the market into the following categories:

Market by Drug Type

  • Innovative Active Pharmaceutical Ingredients
  • Generic Active Pharmaceutical Ingredients

Market by Manufacturer Type

  • Captive Manufacturers
  • Merchant API Manufacturers
    • Innovative Merchant API Manufacturers
    • Generic Merchant API Manufacturers

Market by Synthesis Type

  • Synthetic Active Pharmaceutical Ingredients
    • Innovative Synthetic APIs
    • Generic Synthetic APIs
  • Biotech Active Pharmaceutical Ingredients
  • Market by Drug Type
    • Innovative Biotech APIs
    • Biosimilars
  • Market by Product Type
    • Monoclonal Antibodies
    • Vaccines
    • Cytokines
    • Others
  • Market by Expression System Type
    • Mammalian Expression System
    • Microbial Expression System
    • Yeast Expression System
    • Others

Market by Therapeutic Application

  • Oncology
  • Cardiovascular and Respiratory
  • Diabetes
  • Central Nervous System Disorders
  • Neurological Disorders
  • Others

Key Regions Analyzed

  • United States
  • Canada
  • Mexico

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=1521&flag=C

Key highlights of the Report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Strategic Recommendations
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145

 

 

 

 

 

Comments

Popular posts from this blog

Smart Medical Devices Market Size, Share, Growth Analysis, Report 2024-2032

Brazil Office Furniture Market Size, Share, Industry Growth, Report 2024-32

Interactive Kiosk Market Size, Share, Growth Analysis, Forecast 2023-2028